Heidelberg Epignostix
Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts.
Heidelberg Epignostix is a business in diagnostic based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2024.
Heidelberg Epignostix is positioned in diagnostic, a segment that rewards a clear, focused offering.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Seed stage.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $4.3M in funding.
| Sector | Diagnostic |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | Germany |
| Founded | 2024 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $4,300,000 |
Website: epignostix.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account